Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2018-04, Vol.68 (1), p.S3-S4
Hauptverfasser: Corpechot, C., Rousseau, A., Chazouillères, O., Antonia, L.G., Habersetzer, F., Mathurin, P., Goria, O., Pascal, P., Franza, A.M., Silvain, C., Abergel, A., Gratien, M.D., Larrey, D., Olivier, R., Bronowicki, J.-P., Boursier, J., De Ledinghen, V., Heurgue-Berlot, A., Nguyen-Khac, E., Zoulim, F., Isabelle, O.-H., Zarski, J.-P., Gisèle, N., Farid, G., Admane, F.-H., Simon, T., Poupon, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S4
container_issue 1
container_start_page S3
container_title Journal of hepatology
container_volume 68
creator Corpechot, C.
Rousseau, A.
Chazouillères, O.
Antonia, L.G.
Habersetzer, F.
Mathurin, P.
Goria, O.
Pascal, P.
Franza, A.M.
Silvain, C.
Abergel, A.
Gratien, M.D.
Larrey, D.
Olivier, R.
Bronowicki, J.-P.
Boursier, J.
De Ledinghen, V.
Heurgue-Berlot, A.
Nguyen-Khac, E.
Zoulim, F.
Isabelle, O.-H.
Zarski, J.-P.
Gisèle, N.
Farid, G.
Admane, F.-H.
Simon, T.
Poupon, R.
description
doi_str_mv 10.1016/S0168-8278(18)30226-5
format Article
fullrecord <record><control><sourceid>hal_cross</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03590865v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_03590865v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1321-b2ef0868b2d9b8ef102f1364bc9675e9f95811ada9fe8c8eb2286a6abd68a2613</originalsourceid><addsrcrecordid>eNo9kctOwzAQRS0EEuXxCUhewiJgO43rsCulPESlIko3bKxxYquGEAfbgOAT-SqSFLrxSJ5z74zmInREySkllJ8t2kckgo3EMRUnKWGMJ9kWGlBOSEL4kG6jwQbZRXshPBNCUpIPB-hnGqJ9hahL7G14wV6X70W0rsbO4FfnI1Q2fmGoSxw91KGpoI7QA582rrDS32Cs8q0DtjVu2pauY1g37y8mvdLWUOq3947xOjSuDhpHh5eXk_E5hqapbAH_M-NK4-Vd8i-9rpyCqnfq9wuFay06dQdeTJ-WD4t5u5qF6gDtGKiCPvyr-2h5NX2c3CSz-fXtZDxLCpoymiimDRFcKFbmSmhDCTM05UNV5HyU6dzkmaAUSsiNFoXQijHBgYMquQDGabqPTta-K6hk49vr-S_pwMqb8Ux2fyTN8nZC9tGx2ZotvAvBa7MRUCK78GQfnuySkVTIPjyZpb-2A49i</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial</title><source>Elsevier ScienceDirect Journals</source><creator>Corpechot, C. ; Rousseau, A. ; Chazouillères, O. ; Antonia, L.G. ; Habersetzer, F. ; Mathurin, P. ; Goria, O. ; Pascal, P. ; Franza, A.M. ; Silvain, C. ; Abergel, A. ; Gratien, M.D. ; Larrey, D. ; Olivier, R. ; Bronowicki, J.-P. ; Boursier, J. ; De Ledinghen, V. ; Heurgue-Berlot, A. ; Nguyen-Khac, E. ; Zoulim, F. ; Isabelle, O.-H. ; Zarski, J.-P. ; Gisèle, N. ; Farid, G. ; Admane, F.-H. ; Simon, T. ; Poupon, R.</creator><creatorcontrib>Corpechot, C. ; Rousseau, A. ; Chazouillères, O. ; Antonia, L.G. ; Habersetzer, F. ; Mathurin, P. ; Goria, O. ; Pascal, P. ; Franza, A.M. ; Silvain, C. ; Abergel, A. ; Gratien, M.D. ; Larrey, D. ; Olivier, R. ; Bronowicki, J.-P. ; Boursier, J. ; De Ledinghen, V. ; Heurgue-Berlot, A. ; Nguyen-Khac, E. ; Zoulim, F. ; Isabelle, O.-H. ; Zarski, J.-P. ; Gisèle, N. ; Farid, G. ; Admane, F.-H. ; Simon, T. ; Poupon, R.</creatorcontrib><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/S0168-8278(18)30226-5</identifier><language>eng</language><publisher>Elsevier</publisher><subject>Life Sciences</subject><ispartof>Journal of hepatology, 2018-04, Vol.68 (1), p.S3-S4</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1321-b2ef0868b2d9b8ef102f1364bc9675e9f95811ada9fe8c8eb2286a6abd68a2613</citedby><orcidid>0000-0002-2245-0083 ; 0000-0002-0712-8491 ; 0000-0001-7480-1052 ; 0000-0001-8672-4146</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://u-picardie.hal.science/hal-03590865$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Corpechot, C.</creatorcontrib><creatorcontrib>Rousseau, A.</creatorcontrib><creatorcontrib>Chazouillères, O.</creatorcontrib><creatorcontrib>Antonia, L.G.</creatorcontrib><creatorcontrib>Habersetzer, F.</creatorcontrib><creatorcontrib>Mathurin, P.</creatorcontrib><creatorcontrib>Goria, O.</creatorcontrib><creatorcontrib>Pascal, P.</creatorcontrib><creatorcontrib>Franza, A.M.</creatorcontrib><creatorcontrib>Silvain, C.</creatorcontrib><creatorcontrib>Abergel, A.</creatorcontrib><creatorcontrib>Gratien, M.D.</creatorcontrib><creatorcontrib>Larrey, D.</creatorcontrib><creatorcontrib>Olivier, R.</creatorcontrib><creatorcontrib>Bronowicki, J.-P.</creatorcontrib><creatorcontrib>Boursier, J.</creatorcontrib><creatorcontrib>De Ledinghen, V.</creatorcontrib><creatorcontrib>Heurgue-Berlot, A.</creatorcontrib><creatorcontrib>Nguyen-Khac, E.</creatorcontrib><creatorcontrib>Zoulim, F.</creatorcontrib><creatorcontrib>Isabelle, O.-H.</creatorcontrib><creatorcontrib>Zarski, J.-P.</creatorcontrib><creatorcontrib>Gisèle, N.</creatorcontrib><creatorcontrib>Farid, G.</creatorcontrib><creatorcontrib>Admane, F.-H.</creatorcontrib><creatorcontrib>Simon, T.</creatorcontrib><creatorcontrib>Poupon, R.</creatorcontrib><title>Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial</title><title>Journal of hepatology</title><subject>Life Sciences</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo9kctOwzAQRS0EEuXxCUhewiJgO43rsCulPESlIko3bKxxYquGEAfbgOAT-SqSFLrxSJ5z74zmInREySkllJ8t2kckgo3EMRUnKWGMJ9kWGlBOSEL4kG6jwQbZRXshPBNCUpIPB-hnGqJ9hahL7G14wV6X70W0rsbO4FfnI1Q2fmGoSxw91KGpoI7QA582rrDS32Cs8q0DtjVu2pauY1g37y8mvdLWUOq3947xOjSuDhpHh5eXk_E5hqapbAH_M-NK4-Vd8i-9rpyCqnfq9wuFay06dQdeTJ-WD4t5u5qF6gDtGKiCPvyr-2h5NX2c3CSz-fXtZDxLCpoymiimDRFcKFbmSmhDCTM05UNV5HyU6dzkmaAUSsiNFoXQijHBgYMquQDGabqPTta-K6hk49vr-S_pwMqb8Ux2fyTN8nZC9tGx2ZotvAvBa7MRUCK78GQfnuySkVTIPjyZpb-2A49i</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Corpechot, C.</creator><creator>Rousseau, A.</creator><creator>Chazouillères, O.</creator><creator>Antonia, L.G.</creator><creator>Habersetzer, F.</creator><creator>Mathurin, P.</creator><creator>Goria, O.</creator><creator>Pascal, P.</creator><creator>Franza, A.M.</creator><creator>Silvain, C.</creator><creator>Abergel, A.</creator><creator>Gratien, M.D.</creator><creator>Larrey, D.</creator><creator>Olivier, R.</creator><creator>Bronowicki, J.-P.</creator><creator>Boursier, J.</creator><creator>De Ledinghen, V.</creator><creator>Heurgue-Berlot, A.</creator><creator>Nguyen-Khac, E.</creator><creator>Zoulim, F.</creator><creator>Isabelle, O.-H.</creator><creator>Zarski, J.-P.</creator><creator>Gisèle, N.</creator><creator>Farid, G.</creator><creator>Admane, F.-H.</creator><creator>Simon, T.</creator><creator>Poupon, R.</creator><general>Elsevier</general><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2245-0083</orcidid><orcidid>https://orcid.org/0000-0002-0712-8491</orcidid><orcidid>https://orcid.org/0000-0001-7480-1052</orcidid><orcidid>https://orcid.org/0000-0001-8672-4146</orcidid></search><sort><creationdate>201804</creationdate><title>Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial</title><author>Corpechot, C. ; Rousseau, A. ; Chazouillères, O. ; Antonia, L.G. ; Habersetzer, F. ; Mathurin, P. ; Goria, O. ; Pascal, P. ; Franza, A.M. ; Silvain, C. ; Abergel, A. ; Gratien, M.D. ; Larrey, D. ; Olivier, R. ; Bronowicki, J.-P. ; Boursier, J. ; De Ledinghen, V. ; Heurgue-Berlot, A. ; Nguyen-Khac, E. ; Zoulim, F. ; Isabelle, O.-H. ; Zarski, J.-P. ; Gisèle, N. ; Farid, G. ; Admane, F.-H. ; Simon, T. ; Poupon, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1321-b2ef0868b2d9b8ef102f1364bc9675e9f95811ada9fe8c8eb2286a6abd68a2613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Corpechot, C.</creatorcontrib><creatorcontrib>Rousseau, A.</creatorcontrib><creatorcontrib>Chazouillères, O.</creatorcontrib><creatorcontrib>Antonia, L.G.</creatorcontrib><creatorcontrib>Habersetzer, F.</creatorcontrib><creatorcontrib>Mathurin, P.</creatorcontrib><creatorcontrib>Goria, O.</creatorcontrib><creatorcontrib>Pascal, P.</creatorcontrib><creatorcontrib>Franza, A.M.</creatorcontrib><creatorcontrib>Silvain, C.</creatorcontrib><creatorcontrib>Abergel, A.</creatorcontrib><creatorcontrib>Gratien, M.D.</creatorcontrib><creatorcontrib>Larrey, D.</creatorcontrib><creatorcontrib>Olivier, R.</creatorcontrib><creatorcontrib>Bronowicki, J.-P.</creatorcontrib><creatorcontrib>Boursier, J.</creatorcontrib><creatorcontrib>De Ledinghen, V.</creatorcontrib><creatorcontrib>Heurgue-Berlot, A.</creatorcontrib><creatorcontrib>Nguyen-Khac, E.</creatorcontrib><creatorcontrib>Zoulim, F.</creatorcontrib><creatorcontrib>Isabelle, O.-H.</creatorcontrib><creatorcontrib>Zarski, J.-P.</creatorcontrib><creatorcontrib>Gisèle, N.</creatorcontrib><creatorcontrib>Farid, G.</creatorcontrib><creatorcontrib>Admane, F.-H.</creatorcontrib><creatorcontrib>Simon, T.</creatorcontrib><creatorcontrib>Poupon, R.</creatorcontrib><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Corpechot, C.</au><au>Rousseau, A.</au><au>Chazouillères, O.</au><au>Antonia, L.G.</au><au>Habersetzer, F.</au><au>Mathurin, P.</au><au>Goria, O.</au><au>Pascal, P.</au><au>Franza, A.M.</au><au>Silvain, C.</au><au>Abergel, A.</au><au>Gratien, M.D.</au><au>Larrey, D.</au><au>Olivier, R.</au><au>Bronowicki, J.-P.</au><au>Boursier, J.</au><au>De Ledinghen, V.</au><au>Heurgue-Berlot, A.</au><au>Nguyen-Khac, E.</au><au>Zoulim, F.</au><au>Isabelle, O.-H.</au><au>Zarski, J.-P.</au><au>Gisèle, N.</au><au>Farid, G.</au><au>Admane, F.-H.</au><au>Simon, T.</au><au>Poupon, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial</atitle><jtitle>Journal of hepatology</jtitle><date>2018-04</date><risdate>2018</risdate><volume>68</volume><issue>1</issue><spage>S3</spage><epage>S4</epage><pages>S3-S4</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><pub>Elsevier</pub><doi>10.1016/S0168-8278(18)30226-5</doi><orcidid>https://orcid.org/0000-0002-2245-0083</orcidid><orcidid>https://orcid.org/0000-0002-0712-8491</orcidid><orcidid>https://orcid.org/0000-0001-7480-1052</orcidid><orcidid>https://orcid.org/0000-0001-8672-4146</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0168-8278
ispartof Journal of hepatology, 2018-04, Vol.68 (1), p.S3-S4
issn 0168-8278
1600-0641
language eng
recordid cdi_hal_primary_oai_HAL_hal_03590865v1
source Elsevier ScienceDirect Journals
subjects Life Sciences
title Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T21%3A28%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estimated%20risk%20reduction%20of%20mortality%20and%20transplantation%20with%20bezafibrate%20in%20patients%20with%20PBC%20and%20inadequate%20response%20to%20UDCA:%20application%20of%20the%20UK-PBC%20and%20Global%20PBC%20risk%20scores%20to%20the%20BEZURSO%20trial&rft.jtitle=Journal%20of%20hepatology&rft.au=Corpechot,%20C.&rft.date=2018-04&rft.volume=68&rft.issue=1&rft.spage=S3&rft.epage=S4&rft.pages=S3-S4&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/S0168-8278(18)30226-5&rft_dat=%3Chal_cross%3Eoai_HAL_hal_03590865v1%3C/hal_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true